A former scientist at a British pharmaceutical company pleaded guilty on Monday to stealing trade secrets on behalf of her co-defendants’ Chinese-based pharmaceutical company. The secrets pertain to anti-cancer drugs that can cost in excess of US$1 billion to research and develop, according to the U.S. Department of Justice (DOJ).